Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-05-26
1995-07-18
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 4241331, 530350, 530866, 530868, 935 10, A61K 3817, A61K 39395, C07K 14725, C07K 1900
Patent
active
054341310
ABSTRACT:
The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
J. Cohen Science 257:751 Aug. 7. 1992.
Janeway, "Approaching the Asymptote? Evolution and Revolution in Immunology", Cold Spring Harbor Symp. Quant. Biol. LIV:1-13 (1989).
Shaw and Shimuzu, "Two Molecular Pathways of Human T Cell Adhesion: Establishment of Receptor-Ligand Relationship", Current Opinion in Immunology, Eds. Kindt and Long, 1:92-97 (1988).
Hemler, "Adhesive Protein Receptors on Hematopoietic Cells",Immunology Today 9:109-113 (1988).
Kakiuchi et al., "B Cells as Antigen-Presenting Cells: The Requirement for B Cell Activation", J. Immunol. 131:109-114 (1983).
Krieger et al., "Antigen Presentation by Splenic B Cells: Resting B Cells are Ineffective, Whereas Activated B Cells are Effective Accessory Cells for T Cell Responses", J. Immunol. 135:2937-2945 (1985).
McKenzie, "Alloantigen Presentation by B Cells-Requirement for IL-1 and IL-6", J. Immunol. 141:2907-2911 (1988).
Hawrylowicz and Unanue, "Regulation of Antigen-Presentation-I IFN-.gamma.Induces Antigen-Presenting Properties on B Cells", J. Immunol. 141:4083-4088 (1988).
Springer et al., "The Lymphocyte Function-Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune System", A. Rev. Immunol. 5:223-252 (1987).
Dinarello and Mier, "Current Concepts-Lymphokines", New Engl. Jour. Med. 317:940-945 (1987).
Weiss et al., "The Role of the T3/Antigen Receptor Complex in T-Cell Activation", Ann. Rev. Immunol. 4:593-619 (1986).
McMichael, Ed., "Non-Lineage, LFA-1 Family, and Leucocyte Common Antigens: New and Previously Defined Clusters", Leukocyte Typing III, Oxford Univ. Press, Oxford, UK (1987).
Moingeon et al., "CD2-mediated Adhesion Facilitates T Lymphocyte Antigen Recognition Function", Nature 339:312-314 (1988).
Makgoba et al., "ICAM-1 A Ligand for LFA-1-Dependent Adhesion of B, T and Myeloid Cells", Nature 331:86-88 (1988).
Staunton et al., "Functional Cloning of ICAM-2, A Cell Adhesion Ligand for LFA-1 Homologous to ICAM-1", Nature 339:61-64 (1989).
Norment et al., "Cell-Cell Adhesion Mediated by CD8 and MHC Class I Molecules", Nature 336:79-81 (1988).
Doyle and Strominger, "Interaction Between CD4 and Class II MHC Molecules Mediates Cell Adhesion", Nature 330:256-259 (1987).
Stoolman, "Adhesion Molecules Controlling Lymphocyte Migration", Cell 56:907-910 (1989).
Brescher and Cohn, "A Theory of Self-Nonself Discrimination", Science 169:1042-1049 (1970).
Freeman et al., "B7, A New Member of the Ig Superfamily with Unique Expression on Activated and Neoplastic B Cells", J. Immunol. 143(8):2714-2722 (1989).
Freedman et al., "B7, A B Cell-Restricted Antigen that Identifies Preactivated B Cells", J. Immunol. 138:3260-3267 (1987).
Clark et al., "Polypeptides on Human B Lymphocytes Associated with Cell Activation", Human Immunol. 16:100-113 (1986).
Yokochi et al., "B Lymphoblast Antigen (BB-1) Expressed on Epstein-Barr Virus-Activated B Cells Blasts, B Lymphoblastoid Cell Lines, and Burkitt's Lymphomas", J. Immunol. 128:823:827 (1981).
Weiss, "Structure and Function of the T Cell Antigen Receptor", J. Clin. Invest. 86:1015-1022 (1990).
Allen, "Antigen Processing at the Molecular Level", Immunol. Today 8:270-273 (1987).
Schwartz, "A Cell Culture Model for T Lymphocyte Clonal Anergy", Science 248:1349-1356 (1990).
Weaver and Unanue, "The Costimulatory Function of Antigen-Presenting Cells", Immunol. Today 11:49-55 (1990).
Aruffo and Seed, "Molecular Cloning of a CD28 cDNA by a High-Efficiency COS Cell Expression System", Proc. Natl. Acad. Sci. 84:8573-8577 (1987).
Damle et al., "Alloantigen-Specific Cytotoxic and Supressor T Lymphocytes are Derived from Phenotypically Distinct Precursors", J. Immunol. 131:2296-2300 (1983).
June et al., "T-Cell Proliferation Involving the CD28 Pathway is Associated with Cyclosporine-Resistant Interleukin 2 Gene Expression", Mol. Cell. Biol. 7:4472-4481 (1987).
Thompson et al., "CD28 Activation Pathway Regulates the Production of Multiple T-Cell-Derived Lymphokines/Cytokines", Proc. Natl. Acad. Sci. 86:1333-1337 (1989).
Lindsten et al. "Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway", Science 244:339-343 (1989).
Damle et al., "Monoclonal Antibody Analysis of Human T Lymphocyte Subpopulations Exhibiting Autologous Mixed Lymphocyte Reaction", Proc. Natl. Acad. Sci. 78:5096-5098 (1981).
Lesslauer et al., "T90/44 (9.3 Antigen), A Cell Surface Molecule with a Function in Human T Cell Activation", Eur. J. Immunol. 16:1289-1296 (1986).
Linsley et al., "T-Cell Antigen CD28 Mediates Adhesion with B Cells by Interacting with Activation Antigen B7/BB-1", Proc. Natl. Acad. Sci. USA, 87:5031-5035 (1990).
Linsley et al., "Binding of the B Cell Activation Antigen B7 to CD28 Costimulates T Cell Proliferation and Interleukin 2 mRNA Accumulation", J. Exp. Med. 173:721-730 (1991).
Kohno et al., "CD28 Molecule as a Receptor-Like Function for Accessory Signals in Cell-Mediated Augmentation of IL-2 Production", Cell Immunol. 131:1-10 (1990).
Brunet et al., "A New Member of the Immunoglobulin Superfamily-CTLA-4", Nature 328:267-270 (1987).
Brunet et al., "A Differential Molecular Biology Search for Genes Preferentially Expressed in Functional T Lymphocytes: The CTLA Genes", Immunol. Rev. 103:21-36 (1988).
Dariavach et al., "Human Ig Superfamily CTLA-4 Gene: Chromosomal Localization and Identity of Protein Sequence Between Murine and Human CTLA-4 Cytoplasmic Domains," Eur. J. Immunol. 18:1901-1905 (1988).
Lafage-Pochitaloff et al., "Human CD28 and CTLA-4 Ig Superfamily Genes are Located on Chromosome 2 at Bands q33-q34", Immunogenetics 31:198-201 (1990).
Capon et al., "Designing CD4 Immunoadhesins for AIDS Therapy", Nature 337:525-531 (1989).
Malik et al., "Molecular Cloning, Sequence Analysis, and Functional Expression of a Novel Growth Regulator, Oncostatin M", Molec. and Cell. Biol. 9:2847-2853 (1989).
Storb, "Marrow Transplantation for Severe Aplastic Anemia: Methotrexate Alone Compared with a Combination of Methotrexate and Cyclosporine for Prevention of Acute Graft-Versus-Host Disease", Blood 56:119-125 (1986).
Storb and Thomas, "Graft-Versus-Host Disease in Dog and Man: The Seattle Experience", Immunol. Rev. 88:215-238 (1985).
Aruffo et al., "CD44 is the Principal Cell Surface Receptor for Hyaluronate", Cell 61:1303-1313 (1990).
Seed and Aruffo, "Molecular Cloning of the CD2 antigen, the T-cell Erythrocyte Receptor, by a Rapid Immunoselection Procedure", Proc. Natl. Acad. Sci. 84:3365-3369 (1987).
Aruffo and Seed, "Molecular Cloning of Two CD7 (T-Cell Leukemia Antigen) cDNAs by a COS Cell Expression System", EMBO Hour, 6:3313-3316 (1987).
Ledbetter et al., "Crosslinking of Surface Antigens Causes Mobilization of Intracellular Ionized Calcium in T Lymphocytes", Proc. Natl. Acad. Sci. 84:1384-1388 (1987).
Ledbetter et al., "CD28 Ligation in T-Cell Activation: Evidence for Two Signal Transduction Pathways", Blood 75:1531-1539 (1990).
Damle et al., "Immunoregulatory T Lymphocytes in Man", J. Immunol. 139:1501-1508 (1987).
Wysocki and Sato, "`Panning ` for Lymptocytes: A Method for Cell Selection", Proc. Natl. Acad. Sci. 75:2844-2848 (1978).
Damle et al., "Differential Regulatory Signals Delivered by Antibody Binding to the CD28 (Tp44) Molecule During the Activation of Human T Lymphocytes", J. Immunol. 140:1753-1761 (1988).
Schneck et al., "Inhibition of an Allospecific T Cell Hybridoma by Soluble Class I Proteins and Peptides: Estimation of the Affinity of a T Cell Receptor for MHC", Cell 56:47-55 (1989).
Recny
Brady William
Damle Nitin K.
Ledbetter Jeffrey A.
Linsley Peter S.
Bristol Myers Squibb Co.
Draper Garnette D.
Spector Lorraine M.
LandOfFree
Chimeric CTLA4 receptor and methods for its use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric CTLA4 receptor and methods for its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric CTLA4 receptor and methods for its use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2419018